Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy

American Journal of Ophthalmology

Volumn 136, Issue 5, 2003, Pages 805-813

  Medeiros, Felipe A ^a   Sample, Pamela A ^a   Zangwill, Linda M ^a   Bowd, Christopher ^a   Aihara, Makoto ^a   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORNEA; DISEASE ASSOCIATION; EYE REFRACTION; FAMILY HISTORY; FEMALE; FOLLOW UP; GLAUCOMATOUS OPTIC NEUROPATHY; HAZARD ASSESSMENT; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OPTIC NERVE DISEASE; PERIMETRY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; STEREOPHOTOGRAMMETRY; THICKNESS; VISUAL FIELD; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

EID: 0142257973     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00484-7     Document Type: Article

References (36)

1. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 126:1998;498-505.
2. Heijl A., Leske M.C., Bengtsson B., et al. Reduction of intraocular pressure and glaucoma progression Results from the Early Manifest Glaucoma trial . Arch Ophthalmol. 120:2002;1268-1279.
3. The Advanced Glaucoma Intervention Study (AGIS) 7. The relationship between control of intraocular pressure and visual field deterioration . Am J Ophthalmol. 130:2000;429-440.
4. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma . Arch Ophthalmol. 120:2002;701-713.
5. Johnson M., Kass M.A., Moses R.A., Grodzki W.J. Increased corneal thickness simulating elevated intraocular pressure. Arch Ophthalmol. 96:1978;664-665.
6. Brandt J.D. The influence of corneal thickness on the diagnosis and management of glaucoma. J Glaucoma. 10:(5 Suppl 1):2001;S65-S67.
7. Ehlers N., Bramsen T., Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol (Copenh). 53:1975;34-43.
8. Doughty M.J., Zaman M.L. Human corneal thickness and its impact on intraocular pressure measures A review and meta-analysis approach . Surv Ophthalmol. 44:2000;367-408.
9. Whitacre M.M., Stein R.A., Hassanein K. The effect of corneal thickness on applanation tonometry. Am J Ophthalmol. 115:1993;592-596.
10. Stodtmeister R. Applanation tonometry and correction according to corneal thickness. Acta Ophthalmol Scand. 76:1998;319-324.
11. Argus W.A. Ocular hypertension and central corneal thickness. Ophthalmology. 102:1995;1810-1812.
12. Copt R.P., Thomas R., Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 117:1999;14-16.
13. Brandt J.D., Beiser J.A., Kass M.A., Gordon M.O. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 108:2001;1779-1788.
14. Herman D.C., Hodge D.O., Bourne W.M. Increased corneal thickness in patients with ocular hypertension. Arch Ophthalmol. 119:2001;334-336.
15. Herndon L.W., Choudhri S.A., Cox T., et al. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 115:1997;1137-1141.
16. Wolfs R.C., Klaver C.C., Vingerling J.R., et al. Distribution of central corneal thickness and its association with intraocular pressure The Rotterdam study . Am J Ophthalmol. 123:1997;767-772.
17. Medeiros F.A., Sample P.A., Weinreb R.N. Corneal thickness measurements and visual function abnormalities in ocular hypertensive patients. Am J Ophthalmol. 135:2003;131-137.
18. Medeiros FA, Sample PA, Weinreb RN. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes. Ophthalmology. 2003;110:1902-1907.
19. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study Baseline factors that predict the onset of primary open-angle glaucoma . Arch Ophthalmol. 120:2002;714-720.
20. Jonas J.B., Budde W.M., Panda-Jonas S. Ophthalmoscopic evaluation of the optic nerve head. Surv Ophthalmol. 43:1999;293-320.
21. Johnson C.A., Sample P.A., Cioffi G.A., et al. Structure and Function Evaluation (SAFE) I. Criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP) . Am J Ophthalmol. 134:2002;177-185.
22. Mazumdar M., Glassman J.R. Categorizing a prognostic variable review of methods, code for easy implementation and applications to decision-making about cancer treatments . Stat Med. 19:2000;113-132.
23. Miller R., Siegmund D. Maximally selected chi square statistics. Biometrics. 38:1982;1011-1016.
24. Singh R.P., Goldberg I., Graham S.L., et al. Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension. J Glaucoma. 10:2001;206-210.
25. Emara B.Y., Tingey D.P., Probst L.E., Motolko M.A. Central corneal thickness in low-tension glaucoma. Can J Ophthalmol. 34:1999;319-324.
26. La Rosa F.A., Gross R.L., Orengo-Nania S. Central corneal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations. Arch Ophthalmol. 119:2001;23-27.
27. Schulzer M., Mikelberg F.S., Drance S.M. Some observations on the relation between intraocular pressure reduction and the progression of glaucomatous visual loss. Br J Ophthalmol. 71:1987;486-488.
28. Stewart W.C., Kolker A.E., Sharpe E.D., et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol. 130:2000;274-279.
29. Molteno A.C., Bosma N.J., Kittelson J.M. Otago glaucoma surgery outcome study long-term results of trabeculectomy - 1976 to 1995 . Ophthalmology. 106:1999;1742-1750.
30. Parc C.E., Johnson D.H., Oliver J.E., et al. The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol. 132:2001;27-35.
31. Tezel G., Siegmund K.D., Trinkaus K., et al. Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol. 119:2001;813-818.
32. Shah S., Chatterjee A., Mathai M., et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology. 106:1999;2154-2160.
33. Morad Y., Sharon E., Hefetz L., Nemet P. Corneal thickness and curvature in normal-tension glaucoma. Am J Ophthalmol. 125:1998;164-168.
34. Armaly M.F., Krueger D.E., Maunder L., et al. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol. 98:1980;2163-2171.
35. Suzuki Y., Shirato S., Adachi M., Hamada C. Risk factors for the progression of treated primary open-angle glaucoma a multivariate life-table analysis . Graefes Arch Clin Exp Ophthalmol. 237:1999;463-467.
36. Jonas J.B., Martus P., Budde W.M., et al. Small neuroretinal rim and large parapapillary atrophy as predictive factors for progression of glaucomatous optic neuropathy. Ophthalmology. 109:2002;1561-1567.